Efficacy and Safety of GSK3923868 Inhalation Powder, During Experimental Human Rhinovirus Infection in Participants With Mild Asthma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Phase I Study of Linerixibat in Adults With Moderate Hepatic Impairment and Healthy Controls
- Status
- COMPLETED
- Phase
- PHASE1
EBA, Safety and Tolerability of Sanfetrinem Cilexetil
- Status
- COMPLETED
- Phase
- PHASE2
Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
SCOOT: Sample Collection for DART
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A System to Classify Treatable Traits in Primary Care
- Status
- UNKNOWN
- Phase
- N/A
Comprehensive Outcomes for After Cancer Health
- Status
- RECRUITING
- Phase
- NA
Impact of HPV Vaccination on HPV Infection and Cervical Related Disease Burden in Real-World Settings (HPV-RWS)
- Status
- WITHDRAWN
- Phase
- N/A
A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
- Status
- RECRUITING
- Phase
- PHASE3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- Status
- RECRUITING
- Phase
- PHASE3
Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Immunological Basis for Mepolizumab Activity in COPD
- Status
- UNKNOWN
- Phase
- PHASE2
Study to Monitor the Occurrence of Viral Variants in Patients With Compromised Immune Systems Being Treated for COVID-19
- Status
- COMPLETED
- Phase
- PHASE4
A Study in Healthy Japanese Participants to Evaluate the Safety and Pharmacokinetics of Otilimab
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PARP Inhibition for Gliomas (PI-4G or π4g)
- Status
- TERMINATED
- Phase
- PHASE2
Retrospective Study of the Use of Belantamab Mafodotin (Blenrep®) in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) in Spain.
- Status
- UNKNOWN
- Phase
- N/A
Outcomes of Once-Daily ICS/LABA/LAMA + PRN Respiratory Therapy Treatments in Hospitalized Patients With COPD Exacerbations
- Status
- COMPLETED
- Phase
- PHASE4